Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • North Immunology goes public via reverse merger as eczema drug heads toward clinic

North Immunology goes public via reverse merger as eczema drug heads toward clinic

  • September 17, 2026

North Immunology has decided its path to taking an atopic dermatitis drug into the clinic involves going public via a reverse merger.

Leave A Comment

Fields (*) Mark are Required